Results 11 to 20 of about 34,408 (196)
Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition. [PDF]
PLoS Pathogens, 2023 Primary effusion lymphoma (PEL), a rare aggressive B-cell lymphoma in immunosuppressed patients, is etiologically associated with oncogenic γ-herpesvirus infection.
Xiaojuan Li +4 more
doaj +2 more sources
Primary Effusion Lymphoma without an Effusion: A Rare Case of Solid Extracavitary Variant of Primary Effusion Lymphoma in an HIV-Positive Patient [PDF]
Case Reports in Hematology, 2018 Primary effusion lymphoma (PEL) is a unique form of non-Hodgkin lymphoma, usually seen in severely immunocompromised, HIV-positive patients. PEL is related to human herpesvirus-8 (HHV-8) infection, and it usually presents as a lymphomatous body cavity ...
Hamza Hashmi +3 more
doaj +3 more sources
Primary Effusion Lymphoma [PDF]
Archives of Pathology and Laboratory Medicine, 2013 Primary effusion lymphoma is a large cell non-Hodgkin lymphoma localized predominantly in body cavities and occasionally in extracavitary regions. It presents with characteristic lymphomatous effusions in the absence of solid tumor masses, and pleural, peritoneal, and pericardial spaces are most often involved.
Sanjay, Patel, Philip, Xiao
openaire +3 more sources
Primary effusion lymphoma [PDF]
Blood, 2015 ![Figure][1] A 48-year-old HIV-positive man on highly active retroviral therapy presented with fevers, chills, and a new pleural effusion. Imaging did not identify organomegaly or mass lesions.
Sarah M, Choi, Yi-Hua, Chen
openaire +2 more sources
Clinical Case Reports, 2023 Key Clinical Message HHV8‐ and EBV‐negative primary effusion lymphoma is an extremely rare neoplasm involving body cavities without detectable tumor mass. It usually presents in elderly patients without known immunodeficiency.
Marta Canelo‐Vilaseca +11 more
doaj +1 more source
BMC Cancer, 2021 Background Primary effusion lymphoma is a rare, aggressive large B-cell lymphoma strictly linked to infection by Human Herpes virus 8/Kaposi sarcoma-associated herpes virus.
Magda Zanelli +12 more
doaj +1 more source
MALT1 protease activity in primary effusion lymphoma. [PDF]
Oncotarget, 2018 Bonsignore, L., Juilland, M., Thome, M.
core +4 more sources
Cancer Medicine, 2021 Background Primary human herpesvirus 8 (HHV8)‐unrelated effusion large B‐cell lymphoma is a clinical disease entity distinct from HHV8‐positive primary effusion lymphoma (PEL).
Tomohiro Nishimori +9 more
doaj +1 more source
Primary Cardiac Burkitt’s Lymphoma- A Deadlock [PDF]
Journal of Clinical and Diagnostic Research, 2023 Burkitt’s lymphoma is a high-grade, extremely aggressive form of B-cell non Hodgkin lymphoma with a very fast replication time (tumour doubling time of around 25 hours). The three forms of Burkitt’s lymphoma are documented which include endemic, sporadic,
Vinay Praveen Ayyala +4 more
doaj +1 more source
Primary Effusion Lymphoma [PDF]
The American Journal of Pathology, 2014 CME Accreditation Statement: This activity (“ASIP 2014 AJP CME Program in Pathogenesis”) has been planned and implemented in accordance with the Essential Areas andpolicies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society for Clinical Pathology (ASCP) and theAmerican Society for
Annunziata Gloghini +6 more
openaire +1 more source